SPHERA FUNDS MANAGEMENT LTD.

Q2 2020 13F Holdings Report, Stock Holdings

Signature - Title
Israel Mor - Partner
Location
Tel Aviv, Israel
Holdings as of
30 Jun 2020
Value $
$840,031,000
Num holdings
80
Filing time
13 Aug 2020, 06:02:49 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included ABBV, MRK, SNY, AZN, and JNJ.
Previous filing
Q1 2020 - 14 May 2020
Next filing
Q3 2020 - 12 Nov 2020
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2020 Q2 compared to 2020 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Israel Mor Partner Tel Aviv, Israel 06 Aug 2020

Investment discretion with regard to a portion of the securities reported herein is exercised by Sphera Global Healthcare Management L.P. (the "Management Company"). The Management Company is managed, controlled, and operated by its general partner, Sphera Global Healthcare GP Ltd. (the "General Partner"), the shares of which are owned 50% by Sphera Funds Management Ltd. ("SFML"). SFML is entitled to appoint 50% of the members of the board of directors of the General Partner (the "Board of Directors") and 50% of the members to the investment committee of the Management Company (the "Investment Committee"), and therefore may be deemed to share control of the General Partner and Management Company. This Form 13F shall not be construed as an admission by SFML, the General Partner, or the Management Company that it is the beneficial owner of any of the securities covered by this Form 13F, and each of SFML, the General Partner, and the Management Company disclaim beneficial ownership of any such securities. Per informal guidance received from the Division of Investment Management, section 13(f) securities that are dual listed on a U.S. stock exchange and the Tel Aviv Stock Exchange were included in this Form 13F only if they were purchased in the U.S.

Other Included Managers (2):

Num Name Location File Number
1 Sphera Global Healthcare GP Ltd. Tel Aviv, Israel 028-15864
2 Sphera Global Healthcare Management LP Tel Aviv, Israel 028-15865